Literature DB >> 4880763

Treatment of chronic urinary tract infections with gentamicin.

A A Lindberg, H Bucht, L O Kallings.   

Abstract

Gentamicin was of value in the treatment of chronic urinary tract infections caused by multiresistant bacterial strains for which no atoxic antibiotic was available. The treatment was carried out after alkalinization of the patient's urine. With the dosage given, gentamicin gave a low serum and a relatively high urine concentration. Excretion of active gentamicin in the urine was high even in patients with impaired renal function. The results of treatment of complicated chronic urinary tract infections with initial gentamicin and following long-term therapy showed negative urinary cultures in 12 out of 24 patients within one to 14 months of follow-up time. To reduce the risk of toxic side effects the dosage was adjusted according to the patient's kidney function. No development of resistance was demonstrated in the bacteria.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4880763      PMCID: PMC473567          DOI: 10.1136/jcp.20.5.760

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  GENTAMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA.

Authors:  M J WEINSTEIN; G M LUEDEMANN; E M ODEN; G H WAGMAN; J P ROSSELET; J A MARQUEZ; C T CONIGLIO; W CHARNEY; H L HERZOG; J BLACK
Journal:  J Med Chem       Date:  1963-07       Impact factor: 7.446

2.  GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.

Authors:  J O KLEIN; T C EICKHOFF; M FINLAND
Journal:  Am J Med Sci       Date:  1964-11       Impact factor: 2.378

3.  LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

Authors:  R J BULGER; S SIDELL; W M KIRBY
Journal:  Ann Intern Med       Date:  1963-11       Impact factor: 25.391

4.  PHARMACOLOGY OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

Authors:  J BLACK; B CALESNICK; D WILLIAMS; M J WEINSTEIN
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

5.  TAXONOMY OF GENTAMICIN-PRODUCING MICROMONOSPORA.

Authors:  G M LUEDEMANN; B C BRODSKY
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

6.  CLINICAL EXPERIENCE WITH GENTAMICIN IN GRAM-NEGATIVE INFECTIONS.

Authors:  R L JAO; G G JACKSON
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

7.  ISOLATION, PURIFICATION, AND CHARACTERIZATION OF GENTAMICIN.

Authors:  J P ROSSELET; J MARQUEZ; E MESECK; A MURAWSKI; A HAMDAN; C JOYNER; R SCHMIDT; D MIGLIORE; H L HERZOG
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

8.  Chemotherapeutic and antibiotic drugs in the management of infections of the urinary tract.

Authors:  E H KASS
Journal:  Am J Med       Date:  1955-05       Impact factor: 4.965

9.  Failure of prolonged treatment of chronic urinary-tract infections with antibiotics.

Authors:  M TURCK; A A BROWDER; R I LINDEMEYER; K N BROWN NK ANDERSON; R G PETERSDORF
Journal:  N Engl J Med       Date:  1962-11-15       Impact factor: 91.245

10.  Prolonged treatment of urinary-tract infections with sulfamethoxypyridazine.

Authors:  H G GRIEBLE; G G JACKSON
Journal:  N Engl J Med       Date:  1958-01-02       Impact factor: 91.245

View more
  2 in total

1.  Gentamicin Inhibits Ca2+ Channel TRPV5 and Induces Calciuresis Independent of the Calcium-Sensing Receptor-Claudin-14 Pathway.

Authors:  Wouter H van Megen; Megan R Beggs; Sung-Wan An; Patrícia G Ferreira; Justin J Lee; Matthias T Wolf; R Todd Alexander; Henrik Dimke
Journal:  J Am Soc Nephrol       Date:  2022-01-12       Impact factor: 10.121

2.  Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an In Vitro Model of Intracellular Infection.

Authors:  Françoise Van Bambeke; Marta Putrinš; Ivana Kerkez; Paul M Tulkens; Tanel Tenson
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.